Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DINOPROSTONE Cause Caesarean section? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Caesarean section have been filed in association with DINOPROSTONE (CERVIDIL). This represents 2.8% of all adverse event reports for DINOPROSTONE.

20
Reports of Caesarean section with DINOPROSTONE
2.8%
of all DINOPROSTONE reports
4
Deaths
7
Hospitalizations

How Dangerous Is Caesarean section From DINOPROSTONE?

Of the 20 reports, 4 (20.0%) resulted in death, 7 (35.0%) required hospitalization, and 4 (20.0%) were considered life-threatening.

Is Caesarean section Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DINOPROSTONE. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does DINOPROSTONE Cause?

Foetal exposure during pregnancy (67) Uterine hyperstimulation (65) Off label use (52) Premature separation of placenta (48) Maternal exposure during pregnancy (46) Postpartum haemorrhage (40) Premature baby (40) Drug ineffective (36) Foetal heart rate deceleration abnormality (36) Premature delivery (33)

What Other Drugs Cause Caesarean section?

NATALIZUMAB (421) CERTOLIZUMAB PEGOL (417) INTERFERON BETA-1A (342) ARIPIPRAZOLE (286) EMTRICITABINE\TENOFOVIR DISOPROXIL (273) INFLIXIMAB (216) ADALIMUMAB (188) DIMETHYL (178) RITONAVIR (151) METFORMIN (144)

Which DINOPROSTONE Alternatives Have Lower Caesarean section Risk?

DINOPROSTONE vs DINUTUXIMAB DINOPROSTONE vs DINUTUXIMAB BETA DINOPROSTONE vs DIOSMIN DINOPROSTONE vs DIOSMIN\HESPERIDIN DINOPROSTONE vs DIOVAN

Related Pages

DINOPROSTONE Full Profile All Caesarean section Reports All Drugs Causing Caesarean section DINOPROSTONE Demographics